Table 1.
Baseline demographic and clinical characteristics of three groups
| Point SW | Sweep SW | Control | p value | |
|---|---|---|---|---|
|
Age (years) (mean ± SD) |
45.40 ± 11.49 | 50.55 ± 11.99 | 51 ± 7.77 | 0.18 |
|
Body mass index (mean ± SD) |
27.66 ± 3.64 | 27.36 ± 3.33 | 28.58 ± 3.84 | 0.85 |
| Gender, n (%) | ||||
| Male | 2 (10%) | 2 (10%) | 5 (25%) | 0.3 |
| Female | 18 (90%) | 18 (90%) | 15 (75%) | |
| Symptom duration, n (%) | ||||
| < 1 year | 7 (35%) | 8 (40%) | 8 (40%) | |
| 1–5 years | 7 (35%) | 9 (45%) | 7 (35%) | 0.83 |
| > 5 years | 6 (30%) | 3 (15%) | 5 (25%) | |
|
Pain (VAS) (mean ± SD) |
45.50 ± 12.34 | 39.50 ± 17.00 | 48.00 ± 10.05 | 0.13 |
|
Paresthesia (VAS) (mean ± SD) |
52.0 ± 14.36 | 42.0 ± 16.73 | 46.00 ± 13.13 | 0.10 |
|
BQ (SSS) (mean±SD) |
23.65 ± 5.06 | 21.01 ± 4.84 | 22.44 ± 3.96 | 0.23 |
|
BQ (FSS) (mean ± SD) |
14.88 ± 3.84 | 12.40 ± 3.76 | 13.04 ± 2.80 | 0.088 |
|
SDL (mean ± SD) |
4.34 ± 0.98 | 4.12 ± 0.97 | 4.40 ± 0.82 | 0.60 |
|
MDL (mean±SD) |
4.68 ± 1.09 | 4.22 ± 0.97 | 4.50 ± 0.88 | 0.33 |
SW, shock wave; VAS, visual analog scale; BQ, Boston questionnaire; SSS, symptom severity score; FSS, functional status score; SDL, sensory distal latency; MDL, motor distal latency